Douglas D. Richman
Affiliations: | University of California, San Diego, La Jolla, CA |
Area:
Cell Biology, Microbiology BiologyGoogle:
"Douglas Richman"Children
Sign in to add trainee| Jody L. Fink | grad student | 2002 | UCSD |
| Dennis A. Sheeter | grad student | 2002 | UCSD |
| Satish K. Pillai | grad student | 2005 | UCSD |
| Paula C. Soto | grad student | 2008 | UCSD |
| Mary E. Pacold | grad student | 2010 | UCSD |
| George K. Hightower | grad student | 2011 | UCSD |
| Josue Perez Santiago | grad student | 2012 | UCSD |
| Lorne W. Walker | grad student | 2012 | UCSD |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Inzaule SC, Siedner MJ, Little SJ, et al. (2023) Recommendations on data sharing in HIV drug resistance research. Plos Medicine. 20: e1004293 |
| Beliakova-Bethell N, Manousopoulou A, Deshmukh S, et al. (2022) Integrated proteomics and transcriptomics analyses identify novel cell surface markers of HIV latency. Virology. 573: 50-58 |
| Marques-Gomes J, Salt MJ, Pereira-Neto R, et al. (2021) Development of the HIV360 international core set of outcome measures for adults living with HIV: A consensus process. Hiv Medicine |
| Papasavvas E, Azzoni L, Ross BN, et al. (2021) Intact Human Immunodeficiency Virus (HIV) Reservoir Estimated by the Intact Proviral DNA Assay Correlates With Levels of Total and Integrated DNA in the Blood During Suppressive Antiretroviral Therapy. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 72: 495-498 |
| Vollbrecht T, Angerstein AO, Menke B, et al. (2020) Inconsistent reversal of HIV-1 latency ex vivo by antigens of HIV-1, CMV, and other infectious agents. Retrovirology. 17: 36 |
| Bakkour S, Deng X, Bacchetti P, et al. (2020) Replicate Aptima assay for quantifying residual plasma viremia in individuals on ART. Journal of Clinical Microbiology |
| Abdel-Mohsen M, Richman D, Siliciano RF, et al. (2020) Recommendations for measuring HIV reservoir size in cure-directed clinical trials. Nature Medicine |
| Papasavvas E, Azzoni L, Ross BN, et al. (2020) Intact HIV reservoir estimated by the intact proviral DNA assay correlates with levels of total and integrated DNA in the blood during suppressive antiretroviral therapy. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America |
| Stone M, Rosenbloom D, Bacchetti P, et al. (2020) Assessing suitability of next-generation viral outgrowth assays as proxies for classic QVOA to measure HIV-1 latent reservoir size. The Journal of Infectious Diseases |
| Hermans LE, Carmona S, Nijhuis M, et al. (2020) Virological suppression and clinical management in response to viremia in South African HIV treatment program: A multicenter cohort study. Plos Medicine. 17: e1003037 |